LATS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.21944684852815E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.69626551588453E-12 |
Normal-vs-Stage2 |
1.50979999946621E-07 |
Normal-vs-Stage3 |
1.6561000004689E-07 |
Normal-vs-Stage4 |
2.038400E-02 |
Stage1-vs-Stage2 |
7.382200E-01 |
Stage1-vs-Stage3 |
5.811200E-01 |
Stage1-vs-Stage4 |
7.447200E-01 |
Stage2-vs-Stage3 |
8.808600E-01 |
Stage2-vs-Stage4 |
8.700600E-01 |
Stage3-vs-Stage4 |
9.273800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.73339120834726E-12 |
Normal-vs-AfricanAmerican |
2.26269999958895E-07 |
Normal-vs-Asian |
1.392140E-04 |
Caucasian-vs-AfricanAmerican |
4.579600E-01 |
Caucasian-vs-Asian |
4.880400E-01 |
AfricanAmerican-vs-Asian |
4.544400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63091762317435E-12 |
Normal-vs-Female |
1.14389999994469E-06 |
Male-vs-Female |
1.057680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.44350000420258E-08 |
Normal-vs-Extreme_Weight |
1.6929790902509E-12 |
Normal-vs-Obese |
7.453899997234E-08 |
Normal-vs-Extreme_Obese |
1.588110E-04 |
Normal_Weight-vs-Extreme_Weight |
4.263600E-01 |
Normal_Weight-vs-Obese |
3.548600E-01 |
Normal_Weight-vs-Extreme_Obese |
9.330800E-01 |
Extreme_Weight-vs-Obese |
2.663900E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.175600E-01 |
Obese-vs-Extreme_Obese |
6.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.26940000000298E-05 |
Normal-vs-Age(41-60Yrs) |
3.13359999948304E-07 |
Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
Normal-vs-Age(81-100Yrs) |
3.55830000020596E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.304200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.846000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.556000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.175000E-04 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.042010E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.299400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.66711089377714E-12 |
Normal-VS-Type2 PRCC |
1.33589994621985E-09 |
Normal-VS-KIRP CIMP |
9.73420000000003E-05 |
Normal-VS-Unclassified PRCC |
1.781080E-03 |
Type1 PRCC-VS-Type2 PRCC |
7.384600E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.810600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.619700E-02 |
Type2 PRCC-VS-KIRP CIMP |
9.136200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.832100E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.516000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.19926291120009E-12 |
Normal-vs-N1 |
6.161800E-03 |
Normal-vs-N2 |
6.996300E-03 |
N0-vs-N1 |
3.040300E-02 |
N0-vs-N2 |
6.360400E-01 |
N1-vs-N2 |
5.174000E-01 |
|
|